Filing Details

Accession Number:
0001209191-21-068212
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-06 20:41:53
Reporting Period:
2021-11-29
Accepted Time:
2021-12-06 20:41:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1826892 Bioatla Inc. BCAB Biological Products, (No Disgnostic Substances) (2836) 851922320
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835116 Eric Sievers C/O Bioatla, Inc. 11085 Torreyana Road
San Diego CA 92121
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-11-29 110 $23.89 92,630 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs.
  2. The range of prices for the shares of Common Stock is from $23.75 to $24.11. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price.